A novel anti-arrhythmic drug: the TASK-1 channel tale.

29 August 2020 (09:46 - 09:55)

Organised by:

Video

Sign in for access options

Slides

About the speaker

Professor Constanze Schmidt

University Medical Centre of Gottingen (UMG), Goettingen (Germany)

3 More presentations in this session

Presentation thumbnail

Dietary spermidine: a story of cardioprotection and longevity.

Doctor M. Abdellatif (Graz, AT)

Presentation thumbnail

Mutant KCNJ3 and KCNJ5 potassium channels as novel molecular targets in bradyarrhythmias and atrial fibrillation.

Doctor N. Yamada (Suita, JP)

Presentation thumbnail

Activation of invariant natural killer T cells for heart failure therapy.

Doctor M. Ikeda (Fukuoka, JP)

Access the full session

Session thumbnail

Translating Basic Science Discoveries into Clinical Practice

The Event

ESC Congress 2020

29 August 2020 09:46 CET

You may be interested in

Congress Presentation

State-of-the-art lecture on novel mechanistic insights into arrhythmias

25 August 2023

Congress Presentation

High-density unipolar endocardial mapping before and after ajmaline challenge to assess transmural repolarization gradients in Brugada syndrome: comparison with controls.

14 April 2026

Congress Presentation

Significance of J wave with inverted ST-T polarity induced by ill-timed atrial premature beats and its association with Torsade de Pointes in patients with acute acquired long QT syndrome

31 August 2024

Congress Presentation

Therapeutic effect of selective serotonin reuptake inhibitors to gain-of-function KCND3 variant identified in a patient with early repolarization and refractory epilepsy.

1 September 2025

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources